- Home
- WAVE vs IMRN Comparison
WAVE vs IMRN Comparison
Compare WAVE & IMRN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- WAVE
- IMRN
- Stock Information
- Founded
- WAVE 2011
- IMRN 1994
- Country
- WAVE Israel
- IMRN Australia
- Employees
- WAVE N/A
- IMRN N/A
- Industry
- WAVE Electric Utilities: Central
- IMRN Biotechnology: Pharmaceutical Preparations
- Sector
- WAVE Utilities
- IMRN Health Care
- Exchange
- WAVE Nasdaq
- IMRN Nasdaq
- Market Cap
- WAVE 83.2M
- IMRN 15.0M
- IPO Year
- WAVE 2021
- IMRN N/A
- Fundamental
- Price
- WAVE $13.94
- IMRN $1.96
- Analyst Decision
- WAVE
- IMRN Strong Buy
- Analyst Count
- WAVE 0
- IMRN 1
- Target Price
- WAVE N/A
- IMRN $5.00
- AVG Volume (30 Days)
- WAVE 133.5K
- IMRN 6.0K
- Earning Date
- WAVE 11-21-2024
- IMRN 12-31-2024
- Dividend Yield
- WAVE N/A
- IMRN N/A
- EPS Growth
- WAVE N/A
- IMRN N/A
- EPS
- WAVE N/A
- IMRN N/A
- Revenue
- WAVE $279,000.00
- IMRN $3,271,194.00
- Revenue This Year
- WAVE N/A
- IMRN N/A
- Revenue Next Year
- WAVE N/A
- IMRN N/A
- P/E Ratio
- WAVE N/A
- IMRN N/A
- Revenue Growth
- WAVE 933.33
- IMRN 171.67
- 52 Week Low
- WAVE $1.01
- IMRN $1.59
- 52 Week High
- WAVE $17.63
- IMRN $5.96
- Technical
- Relative Strength Index (RSI)
- WAVE 58.22
- IMRN 45.89
- Support Level
- WAVE $12.99
- IMRN $2.05
- Resistance Level
- WAVE $17.38
- IMRN $2.23
- Average True Range (ATR)
- WAVE 2.24
- IMRN 0.17
- MACD
- WAVE 0.01
- IMRN -0.00
- Stochastic Oscillator
- WAVE 51.57
- IMRN 29.69
About WAVE Eco Wave Power Global AB (publ)
Eco Wave Power Global AB is a Sweden-based wave energy company engaged in the development of a smart and cost-efficient WEC, technology that converts ocean and sea waves into clean electricity. Its WEC technology employs units of point absorber floating devices, referred to as floaters, which are installed on existing marine structures such as piers, breakwaters, and jetties, or in locations in which such marine structures are required. Geographical presence in Israel, USA and Mexico.
About IMRN Immuron Limited
Immuron Ltd is a clinical-stage biopharmaceutical company focused on the development and commercialization of a novel class of immunomodulator polyclonal antibodies to treat liver diseases, infectious diseases and other immune-mediated diseases, such as colitis. The company's product, IMM-124E, is a proprietary immunomodulatory agent targeted at GI immune-mediated diseases including fatty liver diseases. The company functions in two segments namely, Research and Development and Hyperimmune products.